---
title: "GCTK.US (GCTK.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/GCTK.US/news.md"
symbol: "GCTK.US"
name: "GCTK.US"
parent: "https://longbridge.com/zh-CN/quote/GCTK.US.md"
datetime: "2026-03-11T12:55:57.423Z"
locales:
  - [en](https://longbridge.com/en/quote/GCTK.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GCTK.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GCTK.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/GCTK.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GCTK.US/news.md)


# GCTK.US (GCTK.US) — 相关新闻

### [12 Health Care Stocks Moving In Thursday's Intraday Session](https://longbridge.com/zh-CN/news/274184975.md)
*2026-01-29T17:05:41.000Z*
> In Thursday's intraday session, several health care stocks experienced significant movements. ENvue Medical (NASDAQ:FEED

### [Glucotrack Stumbles Despite Winning Patent](https://longbridge.com/zh-CN/news/274170044.md)
*2026-01-29T14:56:18.000Z*
> Glucotrack, Inc. (NASDAQ: GCTK) shares fell 20.8% to $2.70 despite the company receiving three new patents for its conti

### [Glucotrack, Inc. Announces USPTO Approval for CBGM Patents](https://longbridge.com/zh-CN/news/274167253.md)
*2026-01-29T14:33:00.000Z*
> Glucotrack, Inc. announced on January 29, 2026, the issuance of three patents for its continuous blood glucose monitorin

### [GlucoTrack Secures USPTO Patents for Fully Implantable Continuous Blood Glucose Monitoring System](https://longbridge.com/zh-CN/news/274154694.md)
*2026-01-29T13:02:40.000Z*
> GlucoTrack Inc. has received three patents from the US Patent and Trademark Office for its continuous blood glucose moni

### [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://longbridge.com/zh-CN/news/273229419.md)
*2026-01-21T12:05:40.000Z*
> In Wednesday's pre-market session, Anteris Technologies (NASDAQ:AVR) saw a significant gain of 20.7%, reaching $6.94, wi

### [Glucotrack Signs Multiple Material Agreements](https://longbridge.com/zh-CN/news/271245393.md)
*2025-12-31T21:13:00.000Z*
> Glucotrack has signed multiple agreements to raise approximately $4.0 million through a private placement. This includes

### [Glucotrack Reports Q3 2025 Results and Strategic Progress](https://longbridge.com/zh-CN/news/266478412.md)
*2025-11-19T04:05:06.000Z*
> Glucotrack, Inc. reported Q3 2025 results, highlighting a reduced net loss due to decreased revaluation expenses. The co

### [GlucoTrack | 8-K: FY2025 Q3 Revenue: USD 0](https://longbridge.com/zh-CN/news/265791437.md)
*2025-11-13T21:26:10.000Z*